4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AtriCure, Inc. (ATRC) operates in the Medical Instruments & Supplies industry and is headquartered in Mason, United States with about 1,350 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ATRC reported $534M in revenue.
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.
Interactive charts & full statements → Open the ATRC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $534M | $465M | $399M | $330M | — |
| Gross Profit | $401M | $348M | $300M | $246M | — |
| Operating Income (EBIT) | ($9M) | ($40M) | ($27M) | ($43M) | — |
| Net Income | — | ($45M) | ($30M) | ($46M) | $50M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | — | $141M | $140M | $134M | $136M | $124M | — |
| Gross Profit | — | $109M | $105M | $101M | $102M | $93M | — |
| Operating Income (EBIT) | — | $0M | $2M | $0M | ($6M) | ($6M) | — |
| Net Income | — | $0M | $2M | ($0M) | ($6M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $654M | $609M | $614M | $585M | — |
| Total Liabilities | $162M | $148M | $148M | $129M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ATRC viewer.
About TickerBase · Data methodology & sources